X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES TORRENT PHARMA ALKEM LABORATORIES/
TORRENT PHARMA
 
P/E (TTM) x - 36.8 - View Chart
P/BV x 6.7 5.7 116.9% View Chart
Dividend Yield % 0.6 0.9 68.1%  

Financials

 ALKEM LABORATORIES   TORRENT PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
TORRENT PHARMA
Mar-17
ALKEM LABORATORIES/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,5891,768 89.9%   
Low Rs1,2321,186 103.9%   
Sales per share (Unadj.) Rs417.5346.1 120.6%  
Earnings per share (Unadj.) Rs56.355.2 102.0%  
Cash flow per share (Unadj.) Rs64.773.3 88.3%  
Dividends per share (Unadj.) Rs12.7014.00 90.7%  
Dividend yield (eoy) %0.90.9 95.0%  
Book value per share (Unadj.) Rs292.9257.1 114.0%  
Shares outstanding (eoy) m119.57169.22 70.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.44.3 79.2%   
Avg P/E ratio x25.126.8 93.6%  
P/CF ratio (eoy) x21.820.1 108.2%  
Price / Book Value ratio x4.85.7 83.8%  
Dividend payout %22.625.4 88.9%   
Avg Mkt Cap Rs m168,653249,887 67.5%   
No. of employees `000NA11.8 0.0%   
Total wages/salary Rs m9,1719,934 92.3%   
Avg. sales/employee Rs ThNM4,971.5-  
Avg. wages/employee Rs ThNM843.2-  
Avg. net profit/employee Rs ThNM792.4-  
INCOME DATA
Net Sales Rs m49,91558,569 85.2%  
Other income Rs m1,6452,233 73.7%   
Total revenues Rs m51,56160,802 84.8%   
Gross profit Rs m8,48213,773 61.6%  
Depreciation Rs m1,0063,069 32.8%   
Interest Rs m6712,056 32.6%   
Profit before tax Rs m8,45110,881 77.7%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6061,545 103.9%   
Profit after tax Rs m6,7319,336 72.1%  
Gross profit margin %17.023.5 72.3%  
Effective tax rate %19.014.2 133.8%   
Net profit margin %13.515.9 84.6%  
BALANCE SHEET DATA
Current assets Rs m27,06253,841 50.3%   
Current liabilities Rs m15,32431,612 48.5%   
Net working cap to sales %23.538.0 62.0%  
Current ratio x1.81.7 103.7%  
Inventory Days Days6797 68.4%  
Debtors Days Days4184 49.3%  
Net fixed assets Rs m12,61042,079 30.0%   
Share capital Rs m239846 28.3%   
"Free" reserves Rs m34,49042,655 80.9%   
Net worth Rs m35,02743,501 80.5%   
Long term debt Rs m1,21222,408 5.4%   
Total assets Rs m54,387101,250 53.7%  
Interest coverage x13.66.3 216.1%   
Debt to equity ratio x00.5 6.7%  
Sales to assets ratio x0.90.6 158.7%   
Return on assets %13.611.3 121.0%  
Return on equity %19.221.5 89.5%  
Return on capital %24.919.6 126.6%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,56320,066 32.7%   
Fx outflow Rs m3,0125,304 56.8%   
Net fx Rs m3,55214,762 24.1%   
CASH FLOW
From Operations Rs m7,25910,127 71.7%  
From Investments Rs m1,864-7,869 -23.7%  
From Financial Activity Rs m-9,273-1,918 483.5%  
Net Cashflow Rs m-150212 -70.9%  

Share Holding

Indian Promoters % 66.9 71.5 93.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 7.0 471.5%  
FIIs % 0.0 12.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 8.8 -  
Shareholders   68,381 26,511 257.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   NOVARTIS  ASTRAZENECA PHARMA  BIOCON LTD  IPCA LABS  NATCO PHARMA  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

OPEC Meeting; Upcoming IPOs; IDBI Bank, Emami among Top Stocks in Action Today(Pre-Open)

Indian share markets edged up on Friday with Nifty 50 closing above 10,800-levels, even as broader global markets remained weak.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 10.7%

Jun 1, 2018 | Updated on Jun 1, 2018

For the quarter ended March 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 10.7% YoY). Sales on the other hand came in at Rs 17 bn (up 20.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jun 25, 2018 09:23 AM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - FDC LTD. COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS